Indaptus Therapeutics Inc... (INDP)

NasdaqCM: INDP · 실시간 가격 · USD

1.07

+0.01 (0.94%)

종가 기준: Aug 14, 2026, 8:00 PM

0.94% (1D)

데이터 없음

매수호가	0.78
시가총액	142.57M
매출 (ttm)	n/a
순이익 (ttm)	-18.86M
베타	1.18
EPS (ttm)	-12.7
P/E (ttm)	n/a
선행 P/E	-0.77
P/B (ttm)	97.27
P/S (ttm)	n/a
Earnings Date	n/a

매도호가	1.34
거래량	130,789
평균 거래량 (20일)	1,032,104
시가	1.09
전일 종가	1.06
일중 범위	1.02 - 1.15
52주 범위	0.92 - 8.57
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

INDP 소개

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as f...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Aug 4, 2015

직원 수 5

상장 거래소 NasdaqCM

티커 INDP

웹사이트 https://indaptusrx.com

전체 기업 정보